Journal
/
/
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
JoVE Journal
Developmental Biology
A subscription to JoVE is required to view this content.  Sign in or start your free trial.
JoVE Journal Developmental Biology
CRISPR/Cas9 Technology in Restoring Dystrophin Expression in iPSC-Derived Muscle Progenitors
DOI:

07:44 min

September 14, 2019

, , , ,

Chapters

  • 00:04Title
  • 01:45Selecting and Harvesting ES-like Cells
  • 03:02Deletion of Exon 23 in Mouse iPSCs with Two Guide RNAs (gRNAs) coupled with Cas9
  • 05:25Identification of iPSC Colonies with Exon23 Deletion
  • 06:33Results: CRISPR/Cas9-mediated Exon23 Deletion
  • 06:57Conclusion

Summary

Automatic Translation

Here, we present a Cas9-based exon23 deletion protocol to restore dystrophin expression in iPSC from Dmdmdx mouse-derived skin fibroblasts and directly differentiate iPSCs into myogenic progenitor cells (MPC) using the Tet-on MyoD activation system.

Related Videos

Read Article